Provectus Group LLC

Provectus Biopharmaceuticals is a clinical-stage biotechnology company based in San Gabriel, CA, focused on developing safe, affordable, and accessible immunotherapy medicines. Their innovative drug platform utilizes halogenated xanthenes, specifically their lead molecule rose bengal disodium, to address a diverse range of disease areas, including oncology, dermatology, hematology, virology, microbiology, and ophthalmology.

Committed to equitable access, Provectus aims to provide patients, families, and caregivers worldwide with effective treatment options. Through ongoing clinical and non-clinical research, the company seeks to maximize the curative impact of its therapies across various indications.

Generated from the website